Daniel D. Springer - 17 Jun 2024 Form 4 Insider Report for DOCUSIGN, INC. (DOCU)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
17 Jun 2024, 20:12:38 UTC
Prior SEC filing
30 May 2024
Next SEC filing
24 Jun 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Derrick Chapman, Attorney-in-fact

Key filing fact

Daniel D. Springer filed Form 4 for DOCUSIGN, INC. (DOCU) on 17 Jun 2024.

Key facts

  • This page summarizes Daniel D. Springer's Form 4 filing for DOCUSIGN, INC. (DOCU).
  • 4 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 17 Jun 2024, 20:12.

Change

  • Previous filing in this sequence was filed on 30 May 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DOCU transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+5,520
Change %
+0.52%
Price
$0.000000
Shares after
1,068,415
Date
17 Jun 2024
Ownership
Direct
DOCU transaction

Common Stock

Tax liability

Transaction value
$0
Shares
-972
Change %
-0.09%
Price
$0.000000
Shares after
1,067,443
Date
17 Jun 2024
Ownership
Direct
Footnotes
F1
DOCU holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
139,825
Date
17 Jun 2024
Ownership
By Trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DOCU transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-3,338
Change %
-100%
Price
$0.000000*
Shares after
0
Date
17 Jun 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,338
Exercise price
Footnotes
F2, F3, F4
DOCU transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-2,182
Change %
-20%
Price
$0.000000
Shares after
8,728
Date
17 Jun 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,182
Exercise price
Footnotes
F2, F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Represents shares withheld by the Issuer to satisfy a tax obligation realized by the Reporting Person upon the vesting and settlement of restricted stock units.

Footnote F2

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

Footnote F3

The RSUs will vest in sixteen equal quarterly installments over four years, with a vesting commencement date of May 10, 2020, in each case subject to the Reporting Person being a service provider through such date.The restricted stock units are subject to accelerated vesting in the event of a termination of employment of the Reporting Person including under certain circumstances following a change in control of the Issuer.

Footnote F4

The RSUs do not expire; they either vest or are canceled prior to vesting date.

Footnote F5

The RSUs will vest in equal quarterly installments over four years, with a vesting commencement date of May 10, 2021, in each case subject to the Reporting Person being a service provider through each such date. The restricted stock units are subject to accelerated vesting in the event of a termination of employment of the Reporting Person including under certain circumstances following a change in control of the Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .